Back to library
Loading…
cells · Nature Reviews Cancer · 2009
This review discusses the benefits and challenges of targeting the PI3K signalling pathway as a therapeutic strategy in various cancers.
Jeffrey A Engelman
This review discusses the benefits and challenges of targeting the PI3K signalling pathway as a therapeutic strategy in various cancers.